A new study underway at St. David’s Surgical Hospital could help men recover faster and live a better quality of life after ...

Ferring Pharmaceuticals announced today that three abstracts featuring ADSTILADRIN® (nadofaragene firadenovec-vncg) will be presented at the 101st Annual Meeting of the Western Section of the American ...

The NHS is rolling out a pioneering approach to prostate cancer diagnosis, promising to dramatically cut waiting times for ...

STOCKED in every high street pharmacy in Britain, it is a drug that’s meant to ease pain – not cause it. And yet, an ...

Surgeons at Massachusetts General Hospital have removed a pig kidney from a New Hampshire man 271 days after the innovative ...

Circulating tumour DNA-guided adjuvant atezolizumab prolongs disease-free and overall survival in patients with ...

As San Marcos continues to grow, city leaders want to ensure its police department keeps pace. Read More: ...

Enlarged prostate is a common non-cancerous condition that affects older men but many patients wait months for care.

In MIBC patients, ctDNA-guided, adjuvant atezolizumab treatment is associated with significant survival improvements over placebo.

October 17th through the 23rd is Men’s Breast Cancer Awareness Week, a designation made in 2021 under the Biden ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...